These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 17404534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of unresectable stage III non-small-cell lung carcinomas].
    Van Houtte P.
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S24-6. PubMed ID: 17404535
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
    Manegold C, Schirren J, Schneider P, Drings P, Vogt-Moykopf I, Schraube P, Wannenmacher M.
    Pneumologie; 1996 Oct; 50(10):735-41. PubMed ID: 9019754
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L, Robinson LA, Wagner H.
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Non-small cell lung cancer].
    Yoshimura A, Niitani H.
    Ryoikibetsu Shokogun Shirizu; 1994 Feb; (4):100-3. PubMed ID: 8007089
    [No Abstract] [Full Text] [Related]

  • 8. Stage II (T3) lung cancer.
    Allen MS, Jett JR, Kozelsky TF.
    Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
    [Abstract] [Full Text] [Related]

  • 9. [The changed role of chemotherapy in the treatment of stage III non-small-cell lung carcinoma].
    Koning CC.
    Ned Tijdschr Geneeskd; 1997 Jul 26; 141(30):1497-8. PubMed ID: 9542886
    [No Abstract] [Full Text] [Related]

  • 10. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP, Surmont VF.
    Lung Cancer; 2009 Sep 26; 65(3):257-67. PubMed ID: 19285751
    [Abstract] [Full Text] [Related]

  • 11. [Locally advanced and metastatic non-small-cell lung cancer: towards a new optimal therapeutic strategy].
    Fournel P.
    Rev Pneumol Clin; 2004 Jun 26; 60 Spec no 2():2S8-15. PubMed ID: 15211226
    [No Abstract] [Full Text] [Related]

  • 12. [Advanced non-small-cell lung cancer: new effective therapeutic alternatives for tomorrow?].
    Pérol M.
    Rev Pneumol Clin; 2004 Jun 26; 60 Spec no 2():2S20-7. PubMed ID: 15211228
    [No Abstract] [Full Text] [Related]

  • 13. Neoadjuvant therapy for stage III lung cancer.
    Rusch VW.
    Semin Thorac Cardiovasc Surg; 1993 Jul 26; 5(3):258-67. PubMed ID: 8394745
    [No Abstract] [Full Text] [Related]

  • 14. Stage II (N1) lung cancer.
    Choy O, Jahan T, Roach M, You L, Jablons D.
    Chest Surg Clin N Am; 2001 Feb 26; 11(1):39-59, viii. PubMed ID: 11253600
    [Abstract] [Full Text] [Related]

  • 15. Treatment of stage I lung cancer.
    Walsh GL, Pisters KM, Stevens C.
    Chest Surg Clin N Am; 2001 Feb 26; 11(1):17-38, vii. PubMed ID: 11253597
    [Abstract] [Full Text] [Related]

  • 16. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP, De Pauw R, Tournoy K.
    Expert Rev Anticancer Ther; 2008 Feb 26; 8(2):199-206. PubMed ID: 18279061
    [Abstract] [Full Text] [Related]

  • 17. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M, Baumann M, Deppermann M, Freitag L, Gatzemeier U, Huber R, Passlick B, Serke M, Ukena D.
    Pneumologie; 2002 Feb 26; 56(2):113-31. PubMed ID: 11842350
    [No Abstract] [Full Text] [Related]

  • 18. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G.
    Ann Thorac Surg; 2009 Jun 26; 87(6):1676-83. PubMed ID: 19463576
    [Abstract] [Full Text] [Related]

  • 19. [Association of molecular biology of lung cancers and their metastasis and prognosis].
    Mao YS, Gao YN, He J.
    Zhonghua Zhong Liu Za Zhi; 2006 Aug 26; 28(8):632-4. PubMed ID: 17236563
    [No Abstract] [Full Text] [Related]

  • 20. Multimodality approach to management of stage III non-small cell lung cancer.
    Scarpaci A, Mitra P, Jarrar D, Masters GA.
    Surg Oncol Clin N Am; 2013 Apr 26; 22(2):319-28. PubMed ID: 23453337
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.